menu
    • menu

    Company profile for Gemini Therapeutics

    NEW Drugs in Dev: 2
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Gemini Therapeutics is a precision medicine company focused on the development of new therapies through a deeper understanding of disease. We are sharply focused on dry AMD which is a disease comprised of numerous genetic variants. We also believe that more precisely targeted therapeutics could better address the cause of a patient’s disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Gemini TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 One Kendall Square, 3rd Floor Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://geminitherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/geminitherapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/gemini_thera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gemini Therapeutics Presents Aldoxorubicin Data at ASCO 2026
    Gemini Therapeutics Presents Aldoxorubicin Data at ASCO 2026

    27 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260527811954/en/Gemini-Therapeutics-Announces-ASCO-2026-Analyses-Supporting-Aldoxorubicins-Tumor-Targeted-Delivery-and-Cardiac-Safety-Profile

    BUSINESSWIRE
    27 May 2026
    Share Share
    Disc Medicine Announces Completion of Merger with Gemini Therapeutics
    Disc Medicine Announces Completion of Merger with Gemini Therapeutics

    29 Dec 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/disc-medicine-announces-completion-of-merger-with-gemini-therapeutics/?s=79

    BIOSPACE
    29 Dec 2022
    Share Share
    Gemini’s fall gives Disc a way around biotech’s IPO slump
    Gemini’s fall gives Disc a way around biotech’s IPO slump

    11 Aug 2022

    // Gwendolyn Wu BIOPHARMADIVE

    https://www.biopharmadive.com/news/disc-medicine-gemini-reverse-merger-public/629389/

    Gwendolyn Wu BIOPHARMADIVE
    11 Aug 2022
    Share Share
    Gemini Therapeutics Reports 2021 Financial Results
    Gemini Therapeutics Reports 2021 Financial Results

    10 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220310005079/en

    BUSINESSWIRE
    10 Mar 2022
    Share Share
    Gemini Therapeutics Provides GEM103 Program Update
    Gemini Therapeutics Provides GEM103 Program Update

    10 Jan 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220110005346/en

    BUSINESSWIRE
    10 Jan 2022
    Share Share
    Gemini Therapeutics Reports Q3 2021 Financial Results & Provides Business Update
    Gemini Therapeutics Reports Q3 2021 Financial Results & Provides Business Update

    15 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211115005469/en

    BUSINESSWIRE
    15 Nov 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search